Qube Research & Technologies Ltd - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 364 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of EXELIXIS INC
ValueSharesWeighting
Q2 2024$10,798,543
+2730.1%
480,576
+2888.8%
0.02%
+1600.0%
Q1 2024$381,555
-1.1%
16,0790.0%0.00%0.0%
Q4 2023$385,735
-84.7%
16,079
-86.1%
0.00%
-85.7%
Q3 2023$2,519,218
+564.6%
115,296
+481.2%
0.01%
+600.0%
Q2 2023$379,066
-98.6%
19,836
-98.8%
0.00%
-99.3%
Q4 2022$26,802,696
+30.6%
1,670,991
+27.7%
0.14%
+17.2%
Q3 2022$20,522,000
+279.0%
1,308,782
+403.2%
0.12%
+205.0%
Q2 2022$5,415,000
+1014.2%
260,084
+879.2%
0.04%
+900.0%
Q4 2021$486,000
-49.4%
26,561
-37.5%
0.00%
-73.3%
Q1 2021$961,000
-45.1%
42,526
-40.6%
0.02%
-40.0%
Q3 2020$1,752,000
-66.4%
71,642
-67.4%
0.02%
-67.1%
Q2 2020$5,210,000
+1943.1%
219,449
+1382.5%
0.08%
+660.0%
Q1 2020$255,000
+15.9%
14,803
+19.2%
0.01%
-93.2%
Q3 2019$220,000
-30.6%
12,416
-16.3%
0.15%
+96.0%
Q2 2019$317,000
+71.4%
14,832
+41.7%
0.08%
+200.0%
Q3 2018$185,00010,4650.02%
Other shareholders
EXELIXIS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 15,001,073$320,572,00064.48%
Sargent Investment Group, LLC 432,125$9,235,0004.22%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 443,534$9,483,0003.52%
Bellevue Group AG 3,878,800$82,890,0001.42%
CAPITAL MANAGEMENT CORP /VA 237,855$5,083,0001.40%
Orbimed Advisors 3,912,900$83,619,0001.30%
Portolan Capital Management 540,590$11,552,0001.24%
TEALWOOD ASSET MANAGEMENT INC 139,347$2,978,0001.21%
Signition LP 84,120$1,798,000,0001.18%
Penn Capital Management Company, LLC 529,630$11,318,0001.12%
View complete list of EXELIXIS INC shareholders